Significant results for Nyrada’s brain injury treatment
Nyrada Limited (ASX:NYR) CEO James Bonnar discusses results for using NYR-B103 to treat brain injuries. Paul Sanger: I’m Paul Sanger for the Finance News Network, and today I’m talking to Nyrada Inc (ASX:NYR), and they have a market cap of $14m. Nyrada is a drug discovery and development company specialising in novel small-molecule therapeutics to […]
Significant results for Nyrada’s brain injury treatment Read More »